Pacira Biosciences, Inc. (PCRX)
24.91
+0.83
(+3.45%)
USD |
NASDAQ |
Sep 16, 16:00
24.90
-0.01
(-0.04%)
After-Hours: 20:00
Pacira Biosciences Price to Book Value : 1.476 for Sept. 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 1.476 |
| September 15, 2026 | 1.427 |
| September 14, 2026 | 1.463 |
| September 11, 2026 | 1.503 |
| September 10, 2026 | 1.491 |
| September 09, 2026 | 1.534 |
| September 08, 2026 | 1.533 |
| September 04, 2026 | 1.562 |
| September 03, 2026 | 1.576 |
| September 02, 2026 | 1.575 |
| September 01, 2026 | 1.569 |
| August 31, 2026 | 1.535 |
| August 28, 2026 | 1.527 |
| August 27, 2026 | 1.531 |
| August 26, 2026 | 1.535 |
| August 25, 2026 | 1.513 |
| August 24, 2026 | 1.473 |
| August 21, 2026 | 1.462 |
| August 20, 2026 | 1.412 |
| August 19, 2026 | 1.444 |
| August 18, 2026 | 1.422 |
| August 17, 2026 | 1.377 |
| August 14, 2026 | 1.363 |
| August 13, 2026 | 1.374 |
| August 12, 2026 | 1.404 |
| Date | Value |
|---|---|
| August 11, 2026 | 1.445 |
| August 10, 2026 | 1.448 |
| August 07, 2026 | 1.483 |
| August 06, 2026 | 1.516 |
| August 05, 2026 | 1.474 |
| August 04, 2026 | 1.637 |
| August 03, 2026 | 1.595 |
| July 31, 2026 | 1.565 |
| July 30, 2026 | 1.598 |
| July 29, 2026 | 1.564 |
| July 28, 2026 | 1.589 |
| July 27, 2026 | 1.569 |
| July 24, 2026 | 1.534 |
| July 23, 2026 | 1.537 |
| July 22, 2026 | 1.516 |
| July 21, 2026 | 1.528 |
| July 20, 2026 | 1.502 |
| July 17, 2026 | 1.518 |
| July 16, 2026 | 1.517 |
| July 15, 2026 | 1.501 |
| July 14, 2026 | 1.482 |
| July 13, 2026 | 1.514 |
| July 10, 2026 | 1.51 |
| July 09, 2026 | 1.511 |
| July 08, 2026 | 1.512 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zimmer Biomet Holdings, Inc. | 1.461 |
| Liquidia Corp. | 31.26 |
| Johnson & Johnson | 7.575 |
| Merck & Co., Inc. | 8.531 |
| ANI Pharmaceuticals, Inc. | 2.831 |
Price to Book Value Related Metrics
| PE Ratio | 71.77 |
| PS Ratio | 1.408 |
| Price to Free Cash Flow | 5.851 |
| Price | 24.91 |
| Earnings Yield | 1.39% |
| Market Cap | 991.97M |
| Operating PE Ratio | 38.01 |
| Normalized PE Ratio | 51.13 |